Researchers are hard at work identifying ways to help patients with COVID-19, which is caused by the SARS-CoV-2 virus. But in the meantime, one common household object can be used to help prevent infection.
Mayo Clinic is providing coordinated access to investigational convalescent plasma for hospitalized patients with severe or life-threatening COVID-19, or those at high risk of progression to severe or life-threatening disease. The Food and Drug Administration (FDA) announced the designation on April 3.
During this time of the COVID-19 pandemic there has been and continues to be much loss. And different definitions of grief are being revealed. The Mayo Clinic Connect community is opening this conversation and inviting you join.